医生: Roseleen Charania, MD
- 姓 名：Roseleen Charania, MD
- 科 室：内科
- 职 称：
- 就职医院：
- 擅长领域：
- 专家风采
- 专家报道
- 科室团队
- 会诊价格
- 申请专家会诊
Board Certification
Medical Oncology
Hematology
Internal Medicine
Medical School
Goa Medical College, India
Residency
Drexel University College of Medicine, Philadelphia, PA
Fellowship
Hematology & oncology - University of Oklahoma Health Sciences Center, OKlahoma City, OK
Dr. Charania earned her medical degree from Goa Medical College, India. After completing her residency training in Internal Medicine at Drexel University College of Medicine, she attained Board Certification in Internal Medicine in 2007. She has completed her fellowship in Hematology and Medical oncology from the University of Oklahoma Health Sciences Center and obtained her dual Board Certification in 2010. She served as a principle investigator in various studies in Hematology and oncology during her fellowship. She has been in private practice since 2010.
Medical Oncology
Hematology
Internal Medicine
Medical School
Goa Medical College, India
Residency
Drexel University College of Medicine, Philadelphia, PA
Fellowship
Hematology & oncology - University of Oklahoma Health Sciences Center, OKlahoma City, OK
Dr. Charania earned her medical degree from Goa Medical College, India. After completing her residency training in Internal Medicine at Drexel University College of Medicine, she attained Board Certification in Internal Medicine in 2007. She has completed her fellowship in Hematology and Medical oncology from the University of Oklahoma Health Sciences Center and obtained her dual Board Certification in 2010. She served as a principle investigator in various studies in Hematology and oncology during her fellowship. She has been in private practice since 2010.
患者感谢与分享
我要评价
相关资讯新闻more>>
- 告诉癌症患者，癌症全基因检测需要多少钱？
- 非小细胞肺癌突破 新一代肺癌疫苗问世
- 肺癌，乳腺癌，结直肠癌患者福利！美国三位顶级癌症专家联手，为中国患者提供诊疗方案！
- 晚期肺癌患者说，感谢古巴肺癌疫苗，她现在处于缓解状态!
- 快收藏！国内新上市的13种癌症药物适应症，价格大汇总！
- 43名晚期乳腺癌患者用这个方法平均存活667天
- 肺癌复发首选调强质子治疗（IMPT）
- 覆盖50多个国家、7500名肿瘤医生都称赞的基因检测到底有多牛！
- 第二款不分癌种广谱抗癌药首批登陆日本，预计8月美国上市
- 新的生物标志物将为胰腺癌精准治疗打开全新局面
- 梅奥研究证实：这些食管癌患者应该选择质子治疗！
- 个性化益生菌|提供人体免疫力
- 日本癌症细胞免疫治疗的效果和种类
专家会诊实例 more>>
肿瘤快讯
扫描关注我们微信公众号，热线电话：400-666-7998
版权所有·北京环宇达康医疗科技有限责任公司 京ICP备13042754号 京公网安备11010802013088
CopyrightGlobe Cancer, All Rights Reserved
提示：本网站只为患者提供疾病资讯服务和医生咨询服务，任何关于疾病的咨询建议均为参考意见，
由患者、医院和主治医师决定和实施治疗方案，本网站和咨询医师不承担由咨询行为引起的法律责任。